January 15, 2022

Tag: Bio-Tech

Health, San Diego

San Diego’s Sorrento Therapeutics May Be First Viable Vaccine for COVID-19

San Diego-based Sorrento Therapeutics recently announced that its anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration. As announced yesterday Friday May 15th, Sorrento aims to generate an antibody cocktail product that would act as a “protective shield” against SARS-CoV-2 coronavirus infection and […]

Read More